Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | PRKCA | P17252 | 1/20 | 0.34 |
| ▸ | S1PR2 | O95136 | 6/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 6/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | METAP1 | P53582 | 1/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 7/20 | 0.32 |
| ▸ | PTGER3 | P43115 | 6/20 | 0.32 |
| ▸ | PTGER2 | P43116 | 5/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27309683 | 0.86 | PRKCA (0.43) | ALDH1A1PRKCALMNAUSP2HSP90AA1 | |
| SCHEMBL27983508 | 0.84 | PRKCA (0.46) | ALDH1A1PRKCALMNAUSP2HSP90AA1 | |
| Ammonia Solution, Strong SCHEMBL28872308 | 0.84 | PRKCA (0.42) | ALDH1A1PRKCALMNAUSP2HSP90AA1 | |
| SCHEMBL1935917 | 0.84 | PRKCA (0.46) | ALDH1A1PRKCALMNAUSP2HSP90AA1 | |
| SCHEMBL4650754 | 0.84 | PRKCA (0.46) | ALDH1A1PRKCALMNAUSP2HSP90AA1 | |
| SCHEMBL4216173 | 0.78 | METAP1 (0.42) | METAP1 | |
| SCHEMBL5061804 | 0.71 | BRD4 (0.33) | — | |
| SCHEMBL997562 | 0.68 | ALDH1A1 (0.60) | ALDH1A1S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL129229 | 0.68 | PTGS1 (0.53) | ALDH1A1LMNAHSP90AA1MAPTHPGD | |
| SCHEMBL28670321 | 0.68 | CYP2C19 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230181719-A1 | NGR CONJUGATES AND USES THEREOF | OSPEDALE SAN RAFFAELE S.R.L. (IT) | 2023-06-15 | — | — | US | disclosed |
| EP-4121440-A1 | NGR CONJUGATES AND USES THEREOF | Ospedale San Raffaele S.r.l. (IT) | 2023-01-25 | — | — | EP | disclosed |
| US-20220008513-A1 | COMBINED TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA | FONDAZIONE CENTRO SAN RAFFAELE (IT) | 2022-01-13 | — | — | US | disclosed |
| EP-3886824-A1 | COMBINED TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA | Fondazione Centro San Raffaele (IT) | 2021-10-06 | — | — | EP | disclosed |
| WO-2021186071-A1 | NGR CONJUGATES AND USES THEREOF | OSPEDALE SAN RAFFAELE S.R.L. (IT) | 2021-09-23 | — | — | WO | disclosed |
| EP-3882257-A1 | NGR CONJUGATES AND USES THEREOF | Ospedale San Raffaele S.r.l. (IT) | 2021-09-22 | — | — | EP | disclosed |
| WO-2020109625-A1 | COMBINED TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA | FONDAZIONE CENTRO SAN RAFFAELE (IT) | 2020-06-04 | — | — | WO | disclosed |
| US-9782496-B2 | Immunoconjugates for the treatment of tumours | MOLMED SPA (IT) | 2017-10-10 | — | — | US | disclosed |
| US-20170252435-A1 | Combination | MOLMED SPA (IT) | 2017-09-07 | — | — | US | disclosed |
| US-20160074537-A1 | Immunoconjugates for the Treatment of Tumours | MOLMED SPA (IT) | 2016-03-17 | — | — | US | disclosed |
| EP-1499362-A1 | FUSIONS OF CYTOKINES AND TUMOR TARGETING PROTEINS | Molmed SpA (IT) | 2005-01-26 | — | — | EP | disclosed |
| WO-2003093478-A9 | IMMUNOCONJUGATES FOR THE TREATMENT OF TUMOURS | MOLMED SPA (IT) | 2004-12-09 | — | — | WO | disclosed |
| WO-2004041297-A2 | MODIFIED CYTOKINES FOR USE IN CANCER THERAPY | FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR (IT) | 2004-05-21 | — | — | WO | disclosed |
| US-20040018171-A1 | Modified cytokines for use in cancer therapy | FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR | 2004-01-29 | — | — | US | disclosed |
| WO-2003093478-A1 | IMMUNOCONJUGATES FOR THE TREATMENT OF TUMOURS | MOLMED SPA (IT) | 2003-11-13 | — | — | WO | disclosed |
| WO-2003092737-A1 | FUSIONS OF CYTOKINES AND TUMOR TARGETING PROTEINS | MOLMED SPA (IT) | 2003-11-13 | — | — | WO | disclosed |
| US-20030157055-A1 | Modified cytokines for use in cancer therapy | FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR | 2003-08-21 | — | — | US | disclosed |
| US-20030157056-A1 | Modified cytokines for use in cancer therapy | FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR | 2003-08-21 | — | — | US | disclosed |
| EP-1255845-A2 | MODIFIED CYTOKINES FOR USE IN CANCER THERAPY | FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR (IT) | 2002-11-13 | — | — | EP | disclosed |
| WO-2001061017-A2 | MODIFIED CYTOKINES FOR USE IN CANCER THERAPY | FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR (IT) | 2001-08-23 | — | — | WO | disclosed |